New pill takes on tough breast cancer in first human trial
Disease control
Not yet recruiting
This early-phase trial tests an oral drug called Zn-Telomir in 76 adults with advanced or metastatic triple-negative breast cancer that has worsened after prior treatments. The study has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. It is…
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC